An investigation has commenced on behalf of moderna, inc. shareholders. contact levi & korsinsky to discuss your mrna losses

New york, ny / accesswire / june 28, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of moderna, inc. ("moderna") (nasdaq:mrna) concerning possible violations of federal securities laws. moderna issued a press release "announc[ing] that the u.s. food and drug administration (fda) has approved mresvia (mrna-1345), an mrna respiratory syncytial virus (rsv) vaccine, to protect adults aged 60 years and older from lower respiratory tract disease caused by rsv infection.
MRNA Ratings Summary
MRNA Quant Ranking